Analysis of Clinical Factors Associated with Medical Burden and Functional Status in Pyogenic Spine Infection
- PMID: 37048635
- PMCID: PMC10095451
- DOI: 10.3390/jcm12072551
Analysis of Clinical Factors Associated with Medical Burden and Functional Status in Pyogenic Spine Infection
Abstract
Background and purpose: Pyogenic spinal infection (PSI) has recently been on the rise due to aging and increasing degenerative spinal disease related procedures. PSI requires long-term antibiotic treatment and is followed by sustained functional disability even after successful treatment. This study aimed to analyze the clinical factors associated with medical burden and functional status of PSI.
Methods: This retrospective study involved patients with non-postoperative PSI of thoraco-lumbo-sacral area in a single tertiary hospital. The length/cost of hospitalization with an antibiotic therapy and severity of back pain using the short form 36 (SF-36) were defined as the medical burden and functional status, respectively. We analyzed the clinical factors associated with medical burden and functional status.
Results: We enrolled 142 patients (91 males and 51 females). The length and cost of hospitalization were 55.56 ± 27.09 (7-172) days and $14,070.17 ± 9289.39 (1611.87-48,722.35), respectively. A recurrence rate of 7.7% (11/142) and significant improvement of SF-36 at six months after completion of antibiotic treatment were noted (p < 0.05). Procedure-related (OR 2.702), C-reactive protein (CRP; OR 1.062), bacteremia (OR 4.966), additional surgical treatment (OR 6.524), recurrence (OR 12.453), and paraspinal abscess (OR 5.965) for above-average length of hospitalization were observed; female (OR 4.438), CRP (OR 1.071), bacteremia (OR 4.647), additional surgical treatment (OR 6.737), recurrence (OR 22.543), and extent of lesion (OR 1.431) for above-average cost of hospitalization; leg weakness (OR 15.966), white blood cell (WBC; OR 1.116), Charlson's comorbidity index (CCI, OR 1.485), and identification of causative bacteria (OR 2.913) for below-average initial SF-36 were observed; leg weakness (OR 7.975) and WBC (OR 1.094) for below-average 6-month SF-36 were the statistically significant clinical factors in the multivariable logistic regression analysis (p < 0.05).
Conclusion: Recurrence and leg weakness were identified as the most important clinical factors for medical burden and functional status in PSI, respectively. We think that it is necessary to actively suppress recurrence and manage neurological deficits for decreasing medical burden and achieving favorable functional outcome in the treatment of PSI.
Keywords: burden; disability; pyogenic; spine infection; vertebral osteomyelitis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Diagnosis and management of primary pyogenic spinal infections in intravenous recreational drug users.Neurosurg Focus. 2014 Aug;37(2):E3. doi: 10.3171/2014.6.FOCUS14148. Neurosurg Focus. 2014. PMID: 25081963
-
Responsiveness of routine diagnostic tests for vertebral osteomyelitis may be influenced by the infecting organism.Spine J. 2021 Sep;21(9):1479-1488. doi: 10.1016/j.spinee.2021.04.001. Epub 2021 Apr 20. Spine J. 2021. PMID: 33857669
-
Severe Comorbidity Burden Does Not Influence Postoperative Clinical Outcomes and Trajectory for Back Pain, Leg Pain, Physical Function, or Disability in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion: Cohort-Matched Analysis.World Neurosurg. 2022 Aug;164:e157-e168. doi: 10.1016/j.wneu.2022.04.058. Epub 2022 Apr 22. World Neurosurg. 2022. PMID: 35470080
-
Spinal epidural abscesses: risk factors, medical versus surgical management, a retrospective review of 128 cases.Spine J. 2014 Feb 1;14(2):326-30. doi: 10.1016/j.spinee.2013.10.046. Epub 2013 Nov 12. Spine J. 2014. PMID: 24231778 Review.
-
Posterior stabilisation without formal debridement for the treatment of non-tuberculous pyogenic spinal infection in frail and debilitated population - A systematic review and meta-analysis.J Clin Orthop Trauma. 2020 Nov 19;15:9-15. doi: 10.1016/j.jcot.2020.11.009. eCollection 2021 Apr. J Clin Orthop Trauma. 2020. PMID: 33717910 Free PMC article. Review.
Cited by
-
Culture-Negative Native Vertebral Osteomyelitis: A Narrative Review of an Underdescribed Condition.J Clin Med. 2024 Sep 28;13(19):5802. doi: 10.3390/jcm13195802. J Clin Med. 2024. PMID: 39407862 Free PMC article. Review.
-
Risk Factors Associated with Pyogenic Spinal Infections among Intravenous Drug Users and Nonusers.Adv Orthop. 2024 Jul 26;2024:9938159. doi: 10.1155/2024/9938159. eCollection 2024. Adv Orthop. 2024. PMID: 39105127 Free PMC article.
-
Retroperitoneal Continuous Local Antibiotic Perfusion for Refractory Pyogenic Vertebral Osteomyelitis: A Case Report.Cureus. 2023 Dec 16;15(12):e50636. doi: 10.7759/cureus.50636. eCollection 2023 Dec. Cureus. 2023. PMID: 38226091 Free PMC article.
References
-
- Colmenero J.D., Jimenez-Mejias M.E., Sanchez-Lora F.J., Reguera J.M., Palomino-Nicas J., Martos F., Garcia de las Heras J., Pachon J. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: A descriptive and comparative study of 219 cases. Ann. Rheum. Dis. 1997;56:709–715. doi: 10.1136/ard.56.12.709. - DOI - PMC - PubMed
-
- Adam D., Papacocea T., Hornea I., Croitoru R. Postoperative spondylodiscitis. A review of 24 consecutive patients. Chirurgia. 2014;109:90–94. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous